Toxicology assessment
Rigorous evaluation of the potential toxicity and safety profile of your compounds.
Preclinical toxicology overview
At IVRS, we understand that safety is paramount in drug development. Our preclinical toxicology assessment services are designed to rigorously evaluate the potential toxicity and safety profile of your compounds. With our expert team and state-of-the-art facilities, we help you navigate the complexities of drug development, ensuring that your therapeutic agents are both effective and safe.
IVRS provides tailored preclinical toxicology studies combining safety assessment with longitudinal in vivo imaging to evaluate tolerability and monitor early toxicity-related changes throughout treatment.
Safety pharmacology
Evaluate treatment-related effects on vital organ systems and identify potential safety signals during preclinical studies.
Dose & tolerability assessment
Assess dose-related toxicity and tolerability to support dose selection and therapeutic development.
Early toxicity visualization
Use longitudinal in vivo imaging to visualize and monitor early organ and metabolic changes following treatment, helping identify potential toxicity signals before conventional study endpoints.
Tailored toxicology study design
Customize preclinical toxicology studies to the therapeutic candidate, dosing strategy and specific development objectives.
Key capabilities
- Safety pharmacology
- Dose & tolerability assessment
- Early toxicity visualization
- Longitudinal in vivo monitoring
In vivo research services
Preclinical in vivo capabilities
01
In vivo imaging
Advanced in vivo imaging for longitudinal monitoring of disease progression and treatment response.
Read more →
02
Drug validation
Preclinical drug validation to assess therapeutic potential, biological activity and treatment response.
Read more →
03
Drug efficacy
In vivo drug efficacy studies to evaluate therapeutic response, dose effects and treatment outcomes.
Read more →
04
Biodistribution studies
Biodistribution studies to track drug delivery, tissue distribution and target-specific accumulation in vivo.
Read more →
05
Toxicology assessment
Preclinical toxicology studies to evaluate drug safety, tolerability and potential adverse effects.
Read more →
06
Preclinical study design
Customized preclinical study design tailored to disease models, therapeutic targets and drug development goals.
Read more →
Let us help you to thrive
Do you want to learn more about our work and how we can help you?